Drug recall · March 20, 2019
Oxybutynin Chloride Extended-Release Tablets USP 10 mg recall
Why: Failed Dissolution Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478
- Lots / codes
Lots: a) 22738 Exp. 07/2020 and b) 22739 Exp. 07/2020
- Quantity
- a) 2947 and b) 3379
- Company
- AVKARE Inc., Pulaski, TN
- Distribution
- Nationwide.
- Initiated
- March 1, 2019 · Voluntary: Firm initiated
- Classified
- March 11, 2019
- Reported
- March 20, 2019
- Ended
- January 14, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oxybutynin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.